Table of Contents Author Guidelines Submit a Manuscript
Journal of Transplantation
Volume 2017 (2017), Article ID 9731095, 9 pages
https://doi.org/10.1155/2017/9731095
Research Article

Blood Transfusions and Tumor Biopsy May Increase HCC Recurrence Rates after Liver Transplantation

1Department of General, Visceral and Transplantation Surgery, Charité Campus Virchow, Berlin, Germany
2Department of Radiology, Charité Campus Virchow, Berlin, Germany
3Department of Gastroenterology and Hepatology, Charité Campus Virchow, Berlin, Germany

Correspondence should be addressed to Daniel Seehofer; ed.gizpiel-inu.nizidem@refohees.leinad

Received 10 July 2016; Accepted 7 November 2016; Published 5 January 2017

Academic Editor: Yuri Genyk

Copyright © 2017 Daniel Seehofer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Mazzaferro, R. Lencioni, and P. Majno, “Early hepatocellular carcinoma on the procrustean bed of ablation, resection, and transplantation,” Seminars in Liver Disease, vol. 34, no. 4, pp. 415–426, 2014. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Taura, I. Ikai, E. Hatano et al., “Influence of coexisting cirrhosis on outcomes after partial hepatic resection for hepatocellular carcinoma fulfilling the Milan criteria: an analysis of 293 patients,” Surgery, vol. 142, no. 5, pp. 685–694, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Cherqui, A. Laurent, N. Mocellin et al., “Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation,” Annals of Surgery, vol. 250, no. 5, pp. 738–745, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Jonas, W. O. Bechstein, T. Steinmüller et al., “Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis,” Hepatology, vol. 33, no. 5, pp. 1080–1086, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. R. S. Rahimi and J. F. Trotter, “Liver transplantation for hepatocellular carcinoma: outcomes and treatment options for recurrence,” Annals of Gastroenterology, vol. 28, no. 3, pp. 322–330, 2015. View at Google Scholar · View at Scopus
  6. V. Mazzaferro, E. Regalia, R. Doci et al., “Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis,” The New England Journal of Medicine, vol. 334, no. 11, pp. 693–699, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Hoti and R. Adam, “Liver transplantation for primary and metastatic liver cancers,” Transplant International, vol. 21, no. 12, pp. 1107–1117, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Jonas, H. Al-Abadi, C. Benckert et al., “Prognostic significance of the dna-index in liver transplantation for hepatocellular carcinoma in cirrhosis,” Annals of Surgery, vol. 250, no. 6, pp. 1008–1013, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. M. F. Silva and A. J. Wigg, “Current controversies surrounding liver transplantation for hepatocellular carcinoma,” Journal of Gastroenterology and Hepatology, vol. 25, no. 7, pp. 1217–1226, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. S. C. Katz, J. Shia, K. H. Liau et al., “Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma,” Annals of Surgery, vol. 249, no. 4, pp. 617–623, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Vivarelli, A. Cucchetti, G. L. Barba et al., “Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence,” Annals of Surgery, vol. 248, no. 5, pp. 857–862, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Geissler, A. Schnitzbauer, C. Zuelke, P. Lamby, I. Mutzbauer, and H. Schlitt, “The Silver Study: an investigator-initiated trial to determine if sirolimus use can improve HCC recurrence-free survival in affected liver transplant recipients,” Transplantation, vol. 86, pp. 679–680, 2008. View at Publisher · View at Google Scholar
  13. B. Franssen, G. Jibara, P. Tabrizian, M. E. Schwartz, and S. Roayaie, “Actual 10-year survival following hepatectomy for hepatocellular carcinoma,” HPB, vol. 16, no. 9, pp. 830–835, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. M. A. Zimmerman, M. A. Kelly, J. Campsen et al., “The influence of OKT3 therapy on hepatocellular carcinoma recurrence following liver transplantation,” Clinical Transplantation, vol. 24, no. 4, pp. E103–E108, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Toso, S. Merani, D. L. Bigam, A. M. J. Shapiro, and N. M. Kneteman, “Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma,” Hepatology, vol. 51, no. 4, pp. 1237–1243, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Vivarelli, A. Dazzi, M. Zanello et al., “Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma,” Transplantation, vol. 89, no. 2, pp. 227–231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. W. Lasek, M. Plodziszewska, and M. Jakobisiak, “The effect of blood donation on natural killer activity in man,” Journal of Clinical and Laboratory Immunology, vol. 22, no. 4, pp. 165–168, 1987. View at Google Scholar · View at Scopus
  18. E. Ramos, A. Dalmau, A. Sabate et al., “Intraoperative red blood cell transfusion in liver transplantation: influence on patient outcome, prediction of requirements, and measures to reduce them,” Liver Transplantation, vol. 9, no. 12, pp. 1320–1327, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. W. P. van Lawick van Pabst, B. L. A. M. Langenhorst, P. G. H. Mulder, R. L. Marquet, and J. Jeekel, “Effect of perioperative blood loss and perioperative blood transfusions on colorectal cancer survival,” European Journal of Cancer and Clinical Oncology, vol. 24, no. 4, pp. 741–747, 1988. View at Publisher · View at Google Scholar · View at Scopus
  20. R. S. Foster Jr., M. C. Costanza, J. C. Foster, M. C. Wanner, and C. B. Foster, “Adverse relationship between blood transfusions and survival after colectomy for colon cancer,” Cancer, vol. 55, no. 6, pp. 1195–1201, 1985. View at Publisher · View at Google Scholar · View at Scopus
  21. A. G. Little, H.-S. Wu, M. K. Ferguson et al., “Perioperative blood transfusion adversely affects prognosis of patients with stage I non-small-cell lung cancer,” The American Journal of Surgery, vol. 160, no. 6, pp. 630–633, 1990. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Kaneda, T. Horimi, M. Ninomiya et al., “Adverse effect of blood transfusions on survival of patients with gastric cancer,” Transfusion, vol. 27, no. 5, pp. 375–377, 1987. View at Publisher · View at Google Scholar · View at Scopus
  23. P. L. Weiden, M. A. Bean, and P. Schultz, “Perioperative blood transfusion does not increase the risk of colorectal cancer recurrence,” Cancer, vol. 60, no. 4, pp. 870–874, 1987. View at Publisher · View at Google Scholar · View at Scopus
  24. J. Yamamoto, T. Kosuge, T. Takayama et al., “Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy,” Surgery, vol. 115, no. 3, pp. 303–309, 1994. View at Google Scholar · View at Scopus
  25. T. Matsumata, Y. Ikeda, H. Hayashi, T. Kamakura, A. Taketomi, and K. Sugimachi, “The association between transfusion and cancer-free survival after curative resection for hepatocellular carcinoma,” Cancer, vol. 72, no. 6, pp. 1866–1871, 1993. View at Publisher · View at Google Scholar · View at Scopus
  26. A.-H. Kwon, Y. Matsui, and Y. Kamiyama, “Perioperative blood transfusion in hepatocellular carcinomas: influence of immunologic profile and recurrence free survival,” Cancer, vol. 91, no. 4, pp. 771–778, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. T.-B. Liang, D.-L. Li, L. Liang et al., “Intraoperative blood salvage during liver transplantation in patients with hepatocellular carcinoma: efficiency of leukocyte depletion filters in the removal of tumor cells,” Transplantation, vol. 85, no. 6, pp. 863–869, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Fornari, G. Civardi, L. Cavanna et al., “Complications of ultrasonically guided fine-needle abdominal biopsy. Results of a multicenter Italian study and review of the literature. The Cooperative Italian Study Group,” Scandinavian Journal of Gastroenterology, vol. 24, no. 8, pp. 949–955, 1989. View at Publisher · View at Google Scholar
  29. R. Stigliano, L. Marelli, D. Yu, N. Davies, D. Patch, and A. K. Burroughs, “Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? seeding risk for percutaneous approach of HCC,” Cancer Treatment Reviews, vol. 33, no. 5, pp. 437–447, 2007. View at Publisher · View at Google Scholar · View at Scopus
  30. E. H. Smith, “Complications of percutaneous abdominal fine-needle biopsy. Review,” Radiology, vol. 178, no. 1, pp. 253–258, 1991. View at Publisher · View at Google Scholar · View at Scopus
  31. J. Dumortier, C. Lombard-Bohas, P.-J. Valette et al., “Needle tract recurrence of hepatocellular carcinoma after liver transplantation,” Gut, vol. 47, no. 2, article 301, 2000. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Pérez Saborido, J. C. Menéu Díaz, S. Jiménez De Los Galanes et al., “Does preoperative fine needle aspiration-biopsy produce tumor recurrence in patients following liver transplantation for hepatocellular carcinoma?” Transplantation Proceedings, vol. 37, no. 9, pp. 3874–3877, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. K. T. Lopez, S. K. Kuwada, and L. L. Wong, “Consequences of needle tract seeding of hepatocellular cancer after liver transplant,” Clinical Transplantation, vol. 27, no. 4, pp. E400–E406, 2013. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Kosugi, J. Furuse, H. Ishii et al., “Needle tract implantation of hepatocellular carcinoma and pancreatic carcinoma after ultrasound-guided percutaneous puncture: clinical and pathologic characteristics and the treatment of needle tract implantation,” World Journal of Surgery, vol. 28, no. 1, pp. 29–32, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Durand, J. M. Regimbeau, J. Belghiti et al., “Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma,” Journal of Hepatology, vol. 35, no. 2, pp. 254–258, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. W. Ryd, B. Hagmar, and O. Eriksson, “Local tumour cell seeding by fine-needle aspiration biopsy. A semiquantitative study,” Acta Pathologica Microbiologica et Immunologica Scandinavica A, vol. 91, no. 1, pp. 17–21, 1983. View at Google Scholar · View at Scopus
  37. M. Louha, J. Nicolet, H. Zylberberg et al., “Liver resection and needle liver biopsy cause hematogenous dissemination of liver cells,” Hepatology, vol. 29, no. 3, pp. 879–882, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Denecke, C. Grieser, V. Fröling et al., “Multislice computed tomography using a triple-phase contrast protocol for preoperative assessment of hepatic tumor load in patients with hepatocellular carcinoma before liver transplantation,” Transplant International, vol. 22, no. 4, pp. 395–402, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Longerich and P. Schirmacher, “Recent developments in biopsy diagnosis of early and undefined liver tumors,” Zeitschrift fur Gastroenterologie, vol. 47, no. 1, pp. 30–36, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. F. T. Kolligs, R.-T. Hoffmann, M. Op Den Winkel et al., “Diagnosis and multimodal therapy for hepatocellular carcinoma,” Zeitschrift fur Gastroenterologie, vol. 48, no. 2, pp. 274–288, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. M. Adler, F. De Pauw, P. Vereerstraeten et al., “Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system,” Liver Transplantation, vol. 14, no. 4, pp. 526–533, 2008. View at Publisher · View at Google Scholar · View at Scopus